Phenoxyl Radical Complexes of Zinc(II)
J. Am. Chem. Soc., Vol. 119, No. 38, 1997 8899
coulometric experiments were performed with EG&G equipment
(Potentiostat/Galvanostat Model 273A). EPR spectra of complexes
(10-3 M, CH3CN/CH2Cl2 solutions containing 0.10 M [N(n-butyl)4]-
PF6) were measured on a Varian E-9 X-band spectrometer with 100
kHz modulation frequency at 298 K in a quartz cell (d ) 0.3 mm).
The data were digitized by means of the data station Stelar DS-EPR
(Stelar s.n.c., Mede, Italy). The spectra were simulated by iteration of
the isotropic hyperfine coupling constants and line widths. We thank
Dr. F. Neese (Abteilung Biologie der Universita¨t Konstanz) for a copy
of his EPR simulation program. All NMR spectra were recorded on a
400 MHz Bruker AMX series spectrometer.
RR spectra were recorded with a U1000 spectrograph (2400/mm
holographic gratings) equipped with a liquid nitrogen-cooled CCD
detector (Instruments S.A.). The output of a dye laser (stilbene 3;
Coherent 899-01) pumped by an argon ion laser (multiline UV;
Coherent Innova 400) served as excitation source. The laser power at
the sample was about 50 mW. In order to avoid photoinduced
degradation, the sample which exhibits an optical density of ca. 1.5 at
the excitation wavelength was deposited in a rotating cell. The Raman
scattered light was detected at 90° with a scrambler placed in front of
the entrance slit of the spectrometer to account for the polarization-
sensitivity of the gratings. The spectral slit width was 2.8 cm-1. The
spectra, measured with an acquisition time of 15 s, were linearized in
wavenumbers yielding an increment of 0.24 cm-1 and a total spectral
range of ca. 200 cm-1. Thus, several spectra covering different but
overlapping ranges are combined to give the whole spectra displayed
in this work. In these spectra, the contributions of the solvent and the
supporting electrolyte are subtracted.
(CDCl3, 400 MHz): δ 6.76 (d, J ) 2.9 Hz, 1H), 6.39 (d, J ) 2.9 Hz,
1H), 3.73 (s, 2H), 3.72 (s, 3H), 2.88 (t, 4H), 2.63 (t, 4H), 2.51 (s, 4H),
2.33 (s, 6H), 1.39 (s, 9H) ppm. 13C{1H} (CDCl3, 100 MHz): δ 151.3,
150.8, 137.6, 123.5, 112.2, 111.0, 61.8, 58.2, 57.9, 55.5, 53.7, 46.5,
34.7, 29.3 ppm.
[Zn(L1H2)]BF4‚H2O (1) and [Zn(L2H2)]BF4‚H2O (2). A solution
of H3L1 or H3L2 (1.0 mmol) in acetonitrile (50 mL) and Zn(BF4)2‚-
4H2O (0.31 g; 1.0 mmol) was heated to reflux for 2 h. From the cooled
solution colorless microcrystals precipitated which were filtered off;
yield: ∼70%. Anal. Calcd for C51H82BF4N3O4Zn: C, 64.2; H, 8.7;
N, 4.4. Found: C, 63.4; H, 8.5; N, 4.4. Anal. Calcd for C42H63-
BF4N3O7Zn: C, 57.6; H, 7.2; N, 4.8. Found: C, 58.1; H, 7.3; N, 4.9.
The deuterated isotopomers [Zn(d6-L1H2)]BF4‚H2O (d6-1) and [Zn(d6-
L2H2)]BF4‚H2O (d6-2) were prepared analogously by using the deu-
terated ligands d6-H3L1 or d6-H3L2 for the synthesis. 1: 1H NMR
(CD3CN, 400 MHz): δ 7.42 (d, J ) 2.28 Hz, 1H); 7.40 (d, J ) 2.39
Hz, 2H); 7.12 (d, J ) 2.39 Hz, 2H); 7.09 (d, J ) 2.28 Hz, 1H); 3.99
(s, 6H); 2.8 (m, 6H); 2.6 (m, 6H); 1.47 (s, 9H); 1.44 (s, 18H); 1.28 (s,
27H) ppm. 13C{1H} NMR (CD3CN, 100 MHz): δ 152.9, 144.3, 137.4,
127.2, 126.2, 121.6, 60.3, 51.8, 35.5, 35.0, 31.7, 30.9, 30.4 ppm. 2:
1H NMR (CD3CN, 400 MHz): δ 6.92 (d, J ) 3.04 Hz, 3H); 6.68 (d,
J ) 3.04 Hz, 3H); 3.89 (s, 6H); 2.7 (m, 6H); 2.5 (m, 6H); 1.46 (s,
21H); 1.41 (s, 6H). 13C{1H} NMR (CD3CN, 100 MHz): 154.4, 148.8,
139.6, 123.6, 115.4, 114.4, 62.3, 56.2, 51.7, 35.5, 30.7, 30.2 ppm.
[Zn(L2H)] (2a). To a solution of 2 (0.43 g; 0.5 mmol) in CH3OH
(70 mL) was added KOH (0.10 g; 1.7 mmol) at ambient temperature.
Upon stirring for a few minutes a colorless precipitate formed which
was collected by filtration and recrystallized from CH2Cl2 solution. (0.22
g; 56%). Anal. Calcd for C42H61N3O6Zn: C, 65.6; H, 8.0; N, 5.5.
Found: C, 64.8; H, 8.1; N, 5.4. 1H NMR (CD2Cl2, 400 MHz): δ 6.79
(d, J ) 3.20 Hz, 3H); 6.44 (d, J ) 3.20 Hz, 3H); 4.24 (d, J ) 10.78
Hz, 3H); 3.68 (s, 9H); 2.97 (d, J ) 10.78 Hz, 3H); 2.62 (m, 6H); 2.05
(m, 6H); 1.46 (s, 27H) ppm. 13C{1H} (CD2Cl2, 100 Hz): δ 162.6,
146.8, 136.7, 123.7, 114.9, 114.1, 63.5, 57.1, 56.4, 48.2, 34.9, 30.4
ppm.
Treatment of a solution of 2a in CD2Cl2 (∼10-2 M) with 1 equiv of
potassium tert-butyloxide generates a solution of [Zn(L2)]- and tert-
butylhydroxide. The NMR data of 2a are as follows: 1H NMR (CD2-
Cl2, 400 MHz): δ 6.80 (d, J ) 3.28 Hz, 3H); 6.44 (d, J ) 3.28 Hz,
3H); 4.24 (d, J ) 10.78 Hz, 3H); 3.68 (s, 9H); 2.97 (d, J ) 10.78 Hz,
3H); 2.05-2.62 (m, 12H); 1.46 (s, 27H) ppm. 13C{1H} (CD2Cl2, 100
MHz): 162.6, 146.8, 136.7, 123.7, 114.9, 114.1, 63.5, 57.1, 56.5, 48.2,
34.9, 30.4 ppm.
[Zn(L3)(Ph2acac)] (3). To a solution of L3H (0.38 g; 1.0 mmol) in
methanol (30 mL) was added Zn(BF4)2‚4H2O (0.31 g; 1.0 mmol). After
30 min of stirring at room temperature K[Ph2acac] (0.26 g; 1.0 mmol)
was added. Within a few hours, a microcrystalline yellow precipitate
formed which was collected by filtration and recrystallized from diethyl
ether. Recrystallization from a toluene/n-hexane mixture (1:1) produced
yellow single crystals of 3‚0.5toluene‚1n-hexane. The isotopomer [Zn-
(d2-L3)(Ph2acac)] was prepared by using d2-L3H as starting material.
Anal. Calcd for C38H51N3O3Zn: C, 68.8; H, 7.75; N, 6.3. Found: C,
68.8; H, 7.7; N, 6.3. FAB-MS (MNBA): m/z (rel intensity %) 661
{[Zn(L3)(Ph2acac)]+, 55}, 438 {[Zn(L3)]+, 100}; 663 {[d2-Zn(L3)(Ph2-
acac)]+, 55}, 440 {[d2-Zn(L3)]+, 100}. 1H NMR (CDCl3, 400 MHz):
δ 7.90 (m, 4H); 7.36 (m, 6H); 7.08 (d, J ) 2.80 Hz, 1H); 6.73 (d, J )
2.80 Hz, 1H); 6.53 (s, 1H); 4.66 (d, J ) 11.54 Hz, 1H); 3.37 (d, J )
11.54 Hz, 1H), 2.80 (s, 3H); 2.42 (s, 3H); 2.12-3.65 (m, 12H); 1.28
(s, 9H); 1.24 (s, 9H) ppm. 13C{1H} (CDCl3, 100 MHz): δ 186.02,
185.28, 166.74, 142.94, 141.70, 136.49, 130.58, 130.01, 129.68, 127.90,
127.86, 127.15, 127.08, 125.52, 123.00, 119.79, 93.09, 64.36, 57.04,
54.42, 54.26, 52.06, 50.34, 47.20, 47.16, 47.13, 35.08, 33.64, 32.02,
29.75 ppm.
Syntheses. The ligands H3L1 and H3L2 and their isotopomers
deuterated at the benzyl groups have been prepared as described in ref
21.
1,4-Dimethyl-7-(3,5-di-tert-butyl-2-hydroxybenzyl)-1,4,7-triaza-
cyclononane (L3H). To a solution of 2,4-di-tert-butylphenol (30 g;
0.145 mol) in methanol (40 mL) was added dropwise with stirring at
room temperature a suspension of paraformaldehyde (4.5 g; 0.15 mol)
and LiOH‚H2O (0.5 g; 0.012 mol) in methanol (40 mL). The mixture
was heated to reflux for 12 h. The solvent was removed by rotary
evaporation, and the orange-brown viscous residue was dissolved in
n-hexane (20 mL). Upon filtration and storage of the solution at 0 °C
for 12 h, a colorless precipitate of 3,5-di-tert-butyl-2-hydroxybenzyl
alcohol formed (17.5 g; 51%).
The crude product was dissolved in CHCl3 (60 mL), and a solution
of PBr3 (8.1 g; 0.03 mol) in CHCl3 (60 mL) was added dropwise. After
stirring the resulting solution for 1 h at 20 °C water (100 mL) was
added. The organic phase was quickly washed three times with water
and dried over MgSO4, and the solvent was removed by evaporation.
The resulting pale-yellow viscous oil crystallized at 0 °C within a few
days (3,5-di-tert-butyl-2-hydroxybenzyl bromide) (19.5 g; 88%).
To a mixture of 1,4-dimethyl-1,4,7-triazacyclononane (2.0 g; 12.7
mmol) and KOH (1.1 g; 20 mmol) in dry toluene (30 mL) was added
dropwise a solution of 3,5-di-tert-butyl-2-hydroxybenzyl bromide (3.8
g; 12.7 mmol) in toluene (30 mL). The solution was heated to 70 °C
for 6 h. The cooled solution was filtered, and the solvent was removed
by rotary evaporation. A yellow-brown viscous oil of the desired ligand
L1H was obtained which was not further purified but used for the
preparation of complexes. EI-Ms (pos. Ion) m/z 375 (M+) calcd for
C23H40N3O 374.6. 1H NMR (CDCl3, 400 MHz): δ 7.18 (d, J ) 2.52
Hz, 1H), 6.81 (d, J ) 2.52 Hz, 1H), 3.77 (s, 2H), 2.94-2.54 (m, 12H),
2.36 (s, 6H), 1.42 (s, 9H), 1.27 (s, 9H). 13C{1H} (CDCl3, 100 MHz):
154.6, 140.0, 135.4, 123.3, 122.5, 122.0, 62.0, 58.3, 58.0, 53.5, 46.7,
34.8, 34.1, 32.7, 29.6 ppm.
Sodium [1,4-Dimethyl-7-(3-tert-butyl-5-methoxy-2-hydroxyben-
zyl)-1,4,7-triazacyclononane] Na(L4). A solution of 1,4-dimethyl-
1,4,7-triazacyclononane (3.0 g; 19.0 mmol) and paraformaldehyde (0.57
g; 19.0 mmol) in methanol (50 mL) was heated to reflux for 1 h. To
the then yellow solution was added 2-tert-butyl-4-methoxyphenol (3.42
g; 0.019 mol), and heating to reflux was continued for 12 h. The solvent
was removed by rotary evaporation, and the orange-brown viscous
residue was dissolved in dry THF. To this solution was added a small
amount of NaH (0.46 g; 0.019 mol) (caution: very exothermic reaction).
The reaction volume was reduced to one-half by evaporation of THF
and dry diethyl ether (10 mL) and dry n-pentane (30 mL) were added.
A pale-yellow precipitate of Na(L4) formed (2.75 g; 39%). 1H NMR
[Zn(L4)(Ph2acac)] (4). Yellow crystals of 4 were obtained following
the procedure given above for 3 by using Na(L4) as ligand. Yield:
0.25 g (39%). Single crystals for X-ray crystallography were obtained
by recrystallization from acetonitrile/water (1:1) mixture. The isoto-
pomer [Zn(d2-L4)(Ph2acac)] was prepared by using [d2-L4]Na as starting
material. Anal. Calcd for C35H45N3O4Zn: C, 66.0; H, 7.1; N, 6.6.
Found: C, 65.8; H, 7.0; N, 6.6. FAB-MS (MNBA) m/z (rel intensity
%) 636 {[Zn(L4)(Ph2acac)]+, 35}; 412 {[Zn(L4)]+, 100}; 637.4 {[Zn(d2-
L4)(Ph2acac)]+, 50}; 414 {[Zn(d2-L4)]+, 100}. 1H NMR (CDCl3, 400
MHz): δ 7.89 (m, 4H); 7.36 (m, 4H); 6.77 (d, J ) 3.20 Hz, 1H); 6.54